Proton Therapy Systems Market Report 2026

Proton Therapy Systems Market Overview

• Proton Therapy Systems market size has reached to $1.43 billion in 2025 • Expected to grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Harnessing Proton Therapy Systems In Response To Growing Cancer Rates • Market Trend: Advancing Treatment Accessibility With Compact Modular Proton Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Proton Therapy Systems Market?

Proton therapy systems are advanced medical devices used in radiation therapy to treat cancer. These systems deliver proton beams precisely to tumor sites, minimizing damage to surrounding healthy tissue. Proton therapy offers enhanced treatment accuracy and reduced side effects compared to conventional radiation therapy methods. The main types of proton therapy systems are proton therapy systems with robotic positioning tables, proton therapy systems with integrated CT scanners, and proton therapy systems with integrated PET scanners. Proton therapy systems with robotized positioning table systems incorporate a robotic positioning table, enabling precise patient positioning during treatment and ensuring accurate delivery of proton beams to targeted areas, enhancing treatment effectiveness and patient comfort. The setup includes single rooms and multi-rooms for use in applications such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The end-user includes hospitals, proton therapy centers, and others.

What Is The Proton Therapy Systems Market Growth Forecast?

The proton therapy systems market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for image-guided and adaptive proton therapy solutions, rising adoption of compact and single-room proton therapy systems, growing treatment volumes across lung breast and gastrointestinal cancer indications, expanding access to proton therapy in emerging healthcare markets, rising investment in precision oncology and advanced radiotherapy technologies. Major trends in the forecast period include rising adoption of proton therapy for high-precision cancer treatment, increasing utilization of image-guided proton therapy with integrated ct and pet scanners, growing preference for single-room and compact proton therapy system installations, expansion of proton therapy applications across brain head and neck and prostate cancers, increasing deployment of proton therapy centers within hospitals and specialized facilities.

Global Proton Therapy Systems Market Segmentation

1) By Type: Proton Therapy Systems With Robotized Positioning Table, Proton Therapy Systems With Integrated CT Scanner, Proton Therapy Systems With Integrated PET Scanner 2) By Setup Type: Single Room, Multi Room 3) By Application: Brain And Central Nervous System Cancer, Head And Neck Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Other Applications 4) By End-User: Hospitals, Proton Therapy Center, Other End-Users Subsegments: 1) By Proton Therapy Systems With Robotized Positioning Table: Fixed Position Robotized Table Systems, Movable Position Robotized Table Systems 2) By Proton Therapy Systems With Integrated CT Scanner: Conventional CT Scanner Integrated Systems, High-Resolution CT Scanner Integrated Systems 3) By Proton Therapy Systems With Integrated PET Scanner: Low-Dose PET Scanner Integrated Systems, High-Resolution PET Scanner Integrated Systems

What Is The Driver Of The Proton Therapy Systems Market?

The increasing prevalence of cancer is expected to propel the growth of the proton therapy systems market going forward. Cancer is a collection of disorders defined by abnormal cell proliferation that can invade and spread throughout the body. The increasing prevalence of cancer can be attributed to factors such as aging populations, lifestyle changes, environmental exposures, and improved detection and diagnosis methods. Proton therapy systems are used in cancer treatment due to their ability to precisely target tumors with high doses of radiation while minimizing damage to surrounding healthy tissue, potentially reducing side effects, and improving treatment outcomes. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 1,958,310 in 2023, reflecting a growth of 3.16% from 1,898,160 in 2022. Therefore, the increasing prevalence of cancer is driving the development of the proton therapy systems industry.

Key Players In The Global Proton Therapy Systems Market

Major companies operating in the proton therapy systems market are Hitachi Ltd, Ion Beam Applications SA, Sumitomo Heavy Industries Ltd, Mevion Medical Systems, ProNova Solutions LLC, Advanced Oncotherapy plc, Optivus Proton Therapy Inc, ProTom International, P‑Cure Ltd, Mitsubishi Electric Corporation, SHI Group, Aipuqiang Shanghai Aipuqiang Particle Equipment Co Ltd, Maisheng Medical Group, Hefei Zhongke Ionic Medicine Technology Equipment Co Ltd, Elekta AB, B dot Medical Inc, HIL Applied Medical Ltd, Provision Healthcare LLC, Siemens Healthineers AG

Global Proton Therapy Systems Market Trends and Insights

Major companies operating in the proton therapy systems market are focusing their efforts on the development of more compact and accessible systems such as self-shielded proton accelerators, to address challenges related to facility space and installation complexity. A self-shielded proton accelerator enhances safety and simplifies installation by reducing external shielding structures typically required for conventional proton therapy systems. For instance, in September 2024, ProTom International, a US-based medical equipment company, unveiled its latest innovation, the Radiance 330 C proton therapy system. This system, designed as a compact and modular fixed-beam solution, can be installed within or adjacent to existing LINAC vaults. It offers advanced pencil beam scanning technology, upright patient positioning options, and integrated diagnostic-quality CT imaging at the treatment isocentre. The Radiance 330 C aims to make proton therapy more flexible and accessible by reducing facility requirements and supporting future adaptive and image-guided treatment workflows.

What Are Latest Mergers And Acquisitions In The Proton Therapy Systems Market?

In June 2024, Atlantic Health System, a US-based non-profit healthcare network, partnered with Mevion Medical Systems for Atlantic Health System’s plans to acquire and install a MEVION S250-FIT Proton Therapy System. Through this acquisition, Atlantic Health System aims to improve the quality and accessibility of cancer treatment with advanced proton therapy technology. Mevion Medical Systems is a US-based company specializing in the manufacture of proton therapy systems.

Regional Outlook

North America was the largest region in the proton therapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Proton Therapy Systems Market?

The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.